Metabolic Health & Insulin Resistance: What Happens Before Diabetes
AI Overview: Insulin resistance develops when tissues become less responsive to insulin and the pancreas compensates by producing more of it. Glucose and A1C may remain within conventional ranges during this compensated stage. Fasting insulin and HOMA-IR can add useful metabolic context, but they are not stand-alone diagnostic tests. Metabolic assessment may also include glucose, A1C, triglycerides, body composition, visceral fat, liver health, blood pressure, physical activity and other cardiovascular risk factors.
One-Minute Read:
Type 2 diabetes does not usually appear out of nowhere. For many people, insulin sensitivity has been declining for some time before fasting glucose or A1C crosses a diagnostic threshold.
During this period, the pancreas may compensate by producing more insulin. That is one reason we sometimes look beyond glucose alone. Fasting insulin and calculations such as HOMA-IR can provide additional information, although neither should be treated as a diagnosis by itself.
The rest of the metabolic picture matters just as much. Visceral fat, triglycerides, fatty liver, blood pressure, muscle mass, physical activity, sleep and family history can reveal a pattern that one laboratory value cannot.
This is where preventive longevity medicine is useful. The goal is not to invent disease where none exists or chase an arbitrary “optimal” number. It is to recognize meaningful patterns early enough to do something about them.
One of the recurring problems in metabolic medicine is timing.
People often begin paying attention to blood sugar after they have been told they have prediabetes. By then, the physiology that led to the diagnosis may have been developing for years.
Insulin resistance can exist while fasting glucose remains normal. The pancreas simply works harder to keep it there. For some people that compensation continues for a long time. For others, insulin production eventually becomes insufficient to overcome the resistance and glucose begins to rise.
Understanding that progression changes the conversation. We are no longer waiting for diabetes before asking how well the metabolic system is functioning.
For a broader look at the physiology that influences long-term health, see What Actually Moves Longevity Metrics.
What Insulin Resistance Actually Means
Insulin helps regulate the movement and storage of glucose and plays an important role in energy metabolism throughout the body.
With insulin resistance, tissues such as skeletal muscle, liver and adipose tissue become less responsive to insulin signaling. The pancreas may respond by secreting more insulin in an effort to maintain normal glucose levels.
This compensatory phase explains something patients often find confusing: a normal fasting glucose does not necessarily mean that insulin sensitivity is normal.
At the same time, an elevated fasting insulin value is not a diagnosis by itself. Insulin levels vary, laboratory assays are not perfectly standardized, and metabolic health cannot be reduced to one cutoff.
For a simpler explanation of the physiology, see Insulin Resistance Explained.
Glucose, A1C and Insulin Answer Different Questions
Fasting glucose and hemoglobin A1C remain important clinical tests. They are used to identify prediabetes and diabetes and should not be dismissed simply because they may become abnormal later in the process.
What they do not tell us directly is how much insulin the body may be producing to maintain those glucose levels.
That is where fasting insulin can sometimes add context. HOMA-IR combines fasting insulin and fasting glucose into an estimate of insulin resistance. We use these measurements as pieces of a larger metabolic assessment rather than as stand-alone verdicts.
There is no universally accepted HOMA-IR or fasting-insulin cutoff that defines insulin resistance across every population and laboratory. Age, ethnicity, body composition, medications, medical history and the laboratory method itself can affect interpretation.
Read more about Fasting Insulin and Metabolic Health and HOMA-IR and Insulin Resistance.
Body Composition Often Tells Part of the Story
The number on a bathroom scale is a poor description of metabolic health.
Where fat is stored matters. Visceral fat, the fat surrounding abdominal organs, is more metabolically active than subcutaneous fat and is strongly associated with insulin resistance and cardiometabolic risk.
Muscle matters for the opposite reason. Skeletal muscle is one of the body's largest sites for glucose disposal. Maintaining muscle and using it regularly through resistance training and physical activity improves the body's ability to manage glucose.
This is one reason we pay attention to body composition rather than weight alone. Two people of the same height and weight can have very different amounts of muscle and visceral fat, with very different metabolic implications.
The Liver Belongs in the Metabolic Conversation
Insulin resistance frequently overlaps with excess fat in the liver. The condition now called metabolic dysfunction-associated steatotic liver disease, or MASLD, was previously known as NAFLD.
A fatty liver can appear before a person develops diabetes and can occur even when liver enzymes are not dramatically elevated. When it is found, we want to understand the metabolic environment around it rather than treating the liver as an isolated organ.
Read MASLD, NAFLD and Fatty Liver for a more detailed discussion.
Triglycerides Can Be Particularly Revealing
Triglycerides are routinely included on lipid panels, yet they are often overshadowed by cholesterol discussions.
In metabolic assessment, they deserve attention. Elevated triglycerides commonly accompany insulin resistance, visceral adiposity and fatty liver. Their meaning becomes more useful when they are considered alongside glucose regulation, HDL cholesterol, body composition and the broader cardiovascular picture.
Our Triglycerides and Longevity article explains that relationship in greater detail.
What About Inflammation?
Insulin resistance and chronic low-grade inflammation frequently travel together, particularly in the presence of excess visceral fat. The relationship runs in both directions and cannot be explained by one marker.
High-sensitivity C-reactive protein, or hsCRP, can provide information about systemic inflammatory activity and cardiovascular risk. It is not a test for insulin resistance, and an elevated result has many possible causes.
That distinction is important. We use hsCRP as part of the clinical picture, not as proof of a particular metabolic diagnosis.
Sleep Can Change Insulin Sensitivity
Poor sleep does more than make someone tired. Insufficient or fragmented sleep can impair glucose regulation and insulin sensitivity while also affecting appetite, recovery and food choices.
This becomes particularly important when someone is trying to improve metabolic health but continues to sleep five or six disrupted hours a night. Nutrition and exercise still matter, but metabolic physiology does not operate independently of recovery.
See Sleep and Recovery in Longevity Medicine.
Hormonal Transitions Can Change the Picture
Insulin resistance is not caused simply by having “imbalanced hormones,” but hormonal transitions can change body composition, fat distribution, sleep, appetite, muscle mass and insulin sensitivity.
This is particularly relevant during perimenopause and menopause, when changes in estrogen may coincide with increasing visceral fat and worsening insulin sensitivity. Aging men can experience metabolic changes alongside declining muscle mass, altered activity and changing testosterone levels.
Those relationships deserve clinical context rather than a blanket assumption that hormones are responsible for every metabolic problem.
See Hormone Transitions and Longevity Medicine.
The Cardiovascular Connection
Insulin resistance commonly sits inside a larger cardiometabolic pattern that may include hypertension, elevated triglycerides, visceral fat, fatty liver, abnormal glucose regulation and atherogenic lipoprotein abnormalities.
That is why we do not look at insulin resistance as a blood-sugar problem alone. A metabolic assessment should make us more attentive to cardiovascular risk, not less.
For many patients, the important question is not simply, “Will I become diabetic?” It is, “What does this metabolic pattern mean for my arteries, liver, muscle and long-term health?”
What About the Brain?
Metabolic health and brain health are connected through vascular function, inflammation and energy metabolism. Insulin resistance and type 2 diabetes are associated with higher risk of cognitive decline, but that relationship should not be simplified into the claim that elevated insulin directly causes Alzheimer's disease.
The popular phrase “type 3 diabetes” is useful for describing an area of research into brain insulin signaling, but it is not an accepted clinical diagnosis.
For more context, see Fasting Insulin and Brain Health and Brain Insulin Resistance Explained.
What Drives Insulin Resistance?
There is rarely one culprit.
Genetics and family history matter. So do aging, visceral adiposity, physical inactivity, sleep deprivation, overall energy balance and certain medications or medical conditions. Diet matters, but reducing the entire problem to sugar or carbohydrates is an oversimplification.
A person can eat a relatively good diet and still develop insulin resistance. Another may lose substantial metabolic risk through changes in nutrition, activity and body composition. The clinical job is to understand which factors matter most for the individual patient.
What Actually Improves Insulin Sensitivity?
Regular physical activity is one of the most reliable interventions available, and resistance training deserves particular attention because preserving and building muscle improves the body's capacity to use glucose.
Nutrition should support that work. At HormoneSynergy®, we generally favor a plant- and protein-forward Mediterranean pattern rather than a rigid metabolic diet. The details change according to glucose regulation, body composition, activity level, medical history and individual goals.
When excess visceral fat is present, reducing it can substantially improve insulin sensitivity. Sleep and recovery need attention as well. For some patients, medication is appropriate, particularly when prediabetes, diabetes, obesity or other cardiometabolic conditions are present.
The intervention should fit the physiology rather than the latest metabolic trend.
Where Supplements Fit
Supplements may be useful when there is a specific nutritional need or a clinically reasonable indication, but insulin resistance is not corrected by assembling a large supplement stack.
Omega-3 fatty acids, for example, may be useful when triglycerides are elevated and can provide cardiovascular benefit in appropriate patients. Other supplements are sometimes used selectively based on the patient's laboratory findings, diet, medications and overall metabolic picture.
They remain adjuncts. Muscle, physical activity, nutrition, sleep, visceral fat reduction when needed, and appropriate medical therapy have far more influence on the underlying physiology.
The HormoneSynergy® Approach
At HormoneSynergy®, metabolic evaluation does not begin and end with fasting glucose.
Depending on the patient, Dr. Kathryn Retzler may consider glucose and A1C alongside fasting insulin, HOMA-IR, triglycerides, advanced lipids, liver markers, inflammatory markers, blood pressure, hormone status and body composition.
DEXA and SECA testing can add information that a scale cannot provide by helping us see lean mass, total fat and visceral adiposity. Cardiovascular testing may become relevant when the larger risk picture warrants it.
The purpose is not to generate more testing for its own sake. It is to answer a practical question: Is the metabolic system moving in a healthy direction, and if not, what is most likely to change that trajectory?
Medicine, Not Marketing: “Normal” Does Not Tell the Whole Story
We are careful with the phrase “optimal range.” There is a tendency in longevity medicine to assign narrow targets to almost every laboratory value and imply that anything outside them represents hidden disease.
Medicine is rarely that simple.
A laboratory reference range is useful, but a value should still be interpreted in context. Trends, family history, body composition, medications, symptoms and related biomarkers may change its significance.
The goal is not to turn healthy people into patients. The goal is to recognize credible risk early enough to preserve health.
Related Metabolic Health Resources
Frequently Asked Questions
Can you have insulin resistance without diabetes?
Yes. Insulin resistance can develop while the pancreas is still producing enough insulin to keep blood glucose below the thresholds used to diagnose prediabetes or diabetes.
Can fasting glucose be normal when insulin is elevated?
Yes. Higher insulin production can sometimes compensate for reduced insulin sensitivity and maintain normal glucose levels. That pattern should be interpreted in the context of other metabolic findings rather than from fasting insulin alone.
What tests diagnose prediabetes?
Prediabetes is diagnosed using established glucose-based testing such as hemoglobin A1C, fasting plasma glucose or a two-hour oral glucose tolerance test. Fasting insulin and HOMA-IR may provide additional metabolic information but are not standard diagnostic tests for prediabetes.
Is HOMA-IR the best test for insulin resistance?
No single test provides a complete metabolic assessment. HOMA-IR is an estimate derived from fasting insulin and fasting glucose and can be useful clinically, but there is no universal cutoff that applies to every patient or laboratory.
Can insulin resistance improve?
Yes. Insulin sensitivity often improves with regular physical activity, resistance training, appropriate nutrition, improved sleep and reduction of excess visceral fat when present. Medical treatment may also be appropriate depending on the patient's health and risk factors.
Do you have to be overweight to have insulin resistance?
No. People at a normal body weight can develop insulin resistance. Genetics, visceral fat distribution, muscle mass, physical activity, sleep, medications and other medical factors all influence metabolic health.
Does muscle help control blood sugar?
Yes. Skeletal muscle is a major site of glucose uptake, which is one reason maintaining muscle mass and exercising it regularly are important components of metabolic health.
Editorial Transparency
This article is educational and reflects the HormoneSynergy® approach to Preventive Longevity Medicine. It does not diagnose insulin resistance, prediabetes, diabetes or any other medical condition. Laboratory results should be interpreted in the context of medical history, medications, body composition, family history, symptoms and other clinical findings.
Clinical Sources
- National Institute of Diabetes and Digestive and Kidney Diseases — Insulin Resistance & Prediabetes
- NIDDK — Recommended Tests for Identifying Prediabetes
- American Diabetes Association — Standards of Care in Diabetes 2026
This article is part of the HormoneSynergy® Longevity Medicine education series covering preventive cardiology, metabolic health, hormone optimization, body composition, and advanced diagnostics for healthy aging.
Return to the Longevity Medicine Guide →